A case of heterogeneous acute lymphoblastic leukemia of the Burkitt type (L3-ALL) is reported. A 58-year-old womanwas admitted to our hospital with complaints of palpitation and shortness of breath in December 1988. On admission, the peripheral blood showed severe pancytopenia. The bone marrow was hypercellular with abnormal lymphoblasts; the cytoplasm was moderately abundant and intensely basophilic with prominent vacuoles. A diagnosis of L3-ALLwas made. Cytogenetic analysis of bone marrowcells revealed a karyotype of 46,XX. The leukemic blasts were HLA-DR+, CD10+ , CD19+ and CD20+ , but no surface or cytoplasmic immunoglobulins were detected. This is the first report in Japan of a case of L3-ALLwithout chromosome abnormality and lacking surface and cytoplasmic immunoglobulins.
Burkitt type is very rare, accounting for 1-3% of all ALL cases (1, 2) . It is classified as L3-ALL according to the French-American-British (FAB) classification (3). Clinically, the disease is refractory to intensive chemotherapy and often fatal within six months (2, 4) . In addition, it has been shown to possess monoclonal surface immunoglobulin (SIg) (2) , and cytogenetically to have chromosome translocations such as t(8;14), t(8;22) or t (2;8) , associated with the critical breakpoint at 8q24 (5). Although the immunologic and cytogenetic features of L3-ALL are remarkably constant (2, 3, 5) , rare exceptions have been reported recently (1, (6) (7) (8) (9) . We report here a case of L3-ALL without chromosome abnormality and lacking surface and cytoplasmic immunoglobulins.
CASE REPORT
A 58-year-old woman was admitted to our hospital with complaints of palpitation and shortness of breath in December 1988. Physical examination revealed no lymphadenopathy, hepatosplenomegaly or masses. Hematological findings were as follows:
red blood cell count 109 x lOV^l, hemoglobin 3.5 g/dl, platelet count 3.5 x 104/ pt\9 and white blood cell count 1800/ fx \ with 5% bands, 34% segmented neutrophils, 57% lymphocytes, 3% monocytes, 1%basophils and a small number of lymphoblasts. Additional laboratory findings included a serum uric acid level of 6.8 mg/dl and a lactic dehydrogenase level of 276 IU/1 ( Table 1 ). The bone marrow was hypercellular with 96.6% lymphoblasts; the blasts had two or more prominent nucleoli and a moderate amountof basophilic cytoplasm with multiple vacuoles (Fig. 1 ). Cytochemical staining was performed and the blasts were found to be negative for PAS, peroxidase and Unna Table 1 . Laboratory data on admission. ( 1 1 71.0%, CD19+ 67.2% and CD20+ 42.3%. Surface and cytoplasmic immunoglobulins were negative (Table  2 ).
Cytogenetic analysis of bone marrowcells by the G-banding technique revealed a 46,XX karyotype (Fig. 4) . Abdominal echography and a gallium scan were both negative for tumor masses or enlarged lymph nodes. From these findings, a diagnosis of L3-ALL was made. The patient received induction chemotherapy with vincristine, prednisolone, daunorubicin and L-asparaginase and was supported with red blood cell and platelet transfusions. Central nervous system prophylaxis consisted of cranial irradiation at a dose of 1800 rad and intrathecal methotrexate. Four weeks after the initiation of treatment, bone marrow remission was achieved (Fig. 5 ).
DISCUSSION
Wehave reported here a case of heterogeneous Burkitt type ALL. This type of ALLis very rare, accounting for 1 -3% of all ALLcases, and appears mostly in children or very young adults; there are only a few reports of onset of this disease in patients aged over 30 (2, 12, 13) . The main diagnostic criterion for the disease has been L3 morphology according to the FABclassification (3). The leukemic blasts in L3-ALL usually display monoclonal SIg (2) and chromosome translocations, such as t(8;14), t(8,22) or t(2:8), associated with the critical break-point at 8q24 knownto contain the c-myc oncogene (5, 14, 15). The disease is also homogeneous with respect to its very poor prognosis: the remission rate is approximately 50%, and remission duration and survival time are short, typically less than 6 months (2, 4). Furthermore the incidence of central nervous system and abdominal involvement is particularly high (2).
However, heterogeneity of this disease has been reported recently (1 , 6-9) . Three cases of acute nonlymphocytic leukemia, one of erythroleukemia and two of acute myelomonocytic leukemia, have all been reported to have L3 morphology (7). Rarely, T-cell ALL and pre-B cell ALL have also been described to have this morphology (1 , 6 
